Design and Characterization of a Dual COX-2/CaV2.2 Inhibitor with Potent Analgesic Activity
Jie Qiu1, Shouwei Tao1, Tian Zhang1
1Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
None:
Cyclooxygenase-2 (COX-2) and N-type voltage-gated calcium channels (CaV2.2) play pivotal roles in mediating inflammatory responses and regulating neuronal excitability in chronic pain. Concurrent modulation of these targets can achieve synergistic analgesic effects. We designed and synthesized a series of diarylpyrazole-based dual COX-2/CaV2.2 inhibitors. Structure-activity relationship analysis identified compound 5d as the lead candidate, exhibiting balanced inhibitory potency and favorable selectivity against COX-2 and CaV2.2, with IC50 values of 0.26 ± 0.17 μM and 0.29 ± 0.07 μM, respectively. In diverse models of inflammatory, neuropathic, and visceral pain, 5d produced pronounced analgesic effects. By simultaneously suppressing inflammatory responses and disrupting the stepwise amplification of nociceptive signaling, 5d embodies a multimechanistic analgesic strategy meriting further exploration.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Opioid Analgesics: Morphine and Other Natural Cogeners
The Mantel-Cox Log-Rank Test
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Group Design


